TENOFOVIR ALAFENAMIDE

TENOFOVIR ALAFENAMIDE was reported 12081 times

TENOFOVIR ALAFENAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RETROPERITONEAL DISORDER 10 0.4348
1 PERITONEAL THICKENING 10 0.3571
2 ALPHA HYDROXYBUTYRATE DEHYDROGENASE 1 0.3333
3 HEPATITIS D 10 0.1190
4 HEPATITIS B E ANTIGEN POSITIVE 5 0.1190
5 HIV ASSOCIATED NEPHROPATHY 6 0.1176
6 HEPATITIS B DNA ASSAY POSITIVE 15 0.1172
7 ANAL CHLAMYDIA INFECTION 1 0.0833
8 HEPATITIS B DNA INCREASED 35 0.0519
9 RENAL ANEURYSM 11 0.0458
10 PULMONARY VENOUS THROMBOSIS 6 0.0400
11 CONGENITAL SYPHILIS 2 0.0377
12 SEROCONVERSION TEST POSITIVE 2 0.0377
13 PORTAL VENOUS GAS 11 0.0303
14 FAT REDISTRIBUTION 7 0.0302
15 MESENTERIC ARTERY THROMBOSIS 11 0.0286
16 URINE PHOSPHORUS INCREASED 3 0.0275
17 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 8 0.0239
18 HEPATITIS B VIRUS TEST POSITIVE 9 0.0236
19 TOXIC CARDIOMYOPATHY 5 0.0223
20 HEPATITIS B SURFACE ANTIGEN POSITIVE 6 0.0219
21 COLON GANGRENE 2 0.0215
22 ACUTE HEPATITIS B 7 0.0211
23 SECONDARY SYPHILIS 2 0.0202
24 INFECTIVE ANEURYSM 10 0.0202
25 PRIMARY HYPOGONADISM 3 0.0191
26 HYPOPHOSPHATAEMIC OSTEOMALACIA 5 0.0189
27 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 2 0.0180
28 PHARYNGEAL CANCER 3 0.0169
29 RENAL HYPOPLASIA 3 0.0138
30 PARALYSIS RECURRENT LARYNGEAL NERVE 2 0.0137
31 ANTIBODY TEST 1 0.0137
32 FANCONI SYNDROME ACQUIRED 24 0.0137
33 KIDNEY DUPLEX 3 0.0125
34 ABDOMINAL SEPSIS 11 0.0125
35 LIVER TRANSPLANT 45 0.0124
36 RHODOCOCCUS INFECTION 2 0.0120
37 HEPATITIS B 71 0.0118
38 ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED 1 0.0116
39 CONGENITAL RENAL DISORDER 3 0.0113
40 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 4 0.0111
41 ACCESSORY SPLEEN 1 0.0111
42 HEPATITIS B REACTIVATION 35 0.0110
43 VIRAL LOAD INCREASED 42 0.0108
44 HIGH-GRADE B-CELL LYMPHOMA 2 0.0107
45 RENAL TUBULAR DYSFUNCTION 6 0.0106
46 ALPHA 1 FOETOPROTEIN ABNORMAL 1 0.0100
47 STARVATION KETOACIDOSIS 2 0.0099
48 RHEGMATOGENOUS RETINAL DETACHMENT 2 0.0096
49 HIV VIRAEMIA 2 0.0095
50 CHRONIC HEPATITIS B 3 0.0095
51 IMMOBILISATION SYNDROME 2 0.0094
52 LUNG TRANSPLANT REJECTION 6 0.0091
53 MITOCHONDRIAL TOXICITY 7 0.0085
54 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
55 NEONATAL PNEUMONIA 2 0.0085
56 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 42 0.0084
57 HYPERGAMMAGLOBULINAEMIA 4 0.0083
58 SPONTANEOUS BACTERIAL PERITONITIS 2 0.0082
59 BODY DYSMORPHIC DISORDER 3 0.0080
60 GENOTYPE DRUG RESISTANCE TEST POSITIVE 8 0.0078
61 RENAL INFARCT 11 0.0076
62 VIROLOGIC FAILURE 40 0.0074
63 HEPATIC CANCER RECURRENT 2 0.0070
64 ADENOVIRUS REACTIVATION 1 0.0069
65 URGE INCONTINENCE 6 0.0069
66 AMNIOCENTESIS ABNORMAL 1 0.0064
67 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 7 0.0064
68 RENAL TRANSPLANT 23 0.0064
69 FANCONI SYNDROME 9 0.0064
70 CHEMOTHERAPY 24 0.0063
71 LIPODYSTROPHY ACQUIRED 13 0.0061
72 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 2 0.0061
73 HEPATOCELLULAR CARCINOMA 46 0.0060
74 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
75 ALPHA 1 FOETOPROTEIN INCREASED 4 0.0056
76 ALBUMINURIA 3 0.0056
77 VIRAL TEST POSITIVE 2 0.0055
78 SYPHILIS 4 0.0055
79 ANAL FISSURE HAEMORRHAGE 1 0.0054
80 ANASTOMOTIC HAEMORRHAGE 1 0.0053
81 MEDIASTINAL MASS 2 0.0052
82 ASYMPTOMATIC COVID-19 2 0.0051
83 RETINAL TOXICITY 5 0.0049
84 ABDOMINAL CAVITY DRAINAGE 2 0.0047
85 FRACTURE DISPLACEMENT 2 0.0047
86 RENAL SURGERY 3 0.0046
87 HEPATIC ENZYME DECREASED 2 0.0045
88 FEEDING INTOLERANCE 2 0.0044
89 PORTAL VEIN THROMBOSIS 14 0.0043
90 VIRAEMIA 6 0.0043
91 CRYOGLOBULINAEMIA 3 0.0042
92 CYTOMEGALOVIRUS COLITIS 9 0.0039
93 GENITAL ULCERATION 3 0.0039
94 KELOID SCAR 2 0.0039
95 HYDROCELE 4 0.0038
96 STEATOHEPATITIS 2 0.0037
97 TUMOUR RUPTURE 2 0.0036
98 CONGENITAL CYSTIC KIDNEY DISEASE 3 0.0035
99 TRANSPLANT 8 0.0034
100 PROCEDURAL HAEMORRHAGE 13 0.0033
101 OSTEOMALACIA 5 0.0032
102 OESOPHAGEAL VARICES HAEMORRHAGE 7 0.0032
103 BILIARY TRACT INFECTION 2 0.0032
104 PATHOGEN RESISTANCE 29 0.0032
105 HYPERCOAGULATION 6 0.0031
106 DISSEMINATED TUBERCULOSIS 8 0.0031
107 COUNTERFEIT PRODUCT ADMINISTERED 4 0.0031
108 CHRONIC MYELOMONOCYTIC LEUKAEMIA 2 0.0030
109 SINGLE FUNCTIONAL KIDNEY 2 0.0030
110 BLOOD PHOSPHORUS DECREASED 11 0.0030
111 MULTIPLE-DRUG RESISTANCE 9 0.0029
112 SCROTAL OEDEMA 2 0.0028
113 GASTROINTESTINAL TUBE INSERTION 7 0.0028
114 LIPIDS ABNORMAL 2 0.0028
115 HYPOPHOSPHATAEMIA 20 0.0027
116 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
117 CHRONIC GASTRITIS 6 0.0027
118 MULTIPLE DRUG THERAPY 2 0.0027
119 HIV INFECTION 8 0.0027
120 GASTROSTOMY 4 0.0026
121 IMMUNE-MEDIATED HEPATIC DISORDER 5 0.0026
122 DYSLIPIDAEMIA 13 0.0026
123 EXPOSURE VIA BODY FLUID 2 0.0025
124 SUSPECTED COUNTERFEIT PRODUCT 10 0.0025
125 HISTOPLASMOSIS DISSEMINATED 4 0.0025
126 ANKYLOGLOSSIA CONGENITAL 1 0.0025
127 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 1 0.0025
128 CRYPTOCOCCOSIS 4 0.0025
129 VIRAL MUTATION IDENTIFIED 9 0.0024
130 POLYCYTHAEMIA 5 0.0024
131 PERITONEAL DIALYSIS 2 0.0024
132 INTENTIONAL DOSE OMISSION 69 0.0024
133 RENAL ATROPHY 3 0.0024
134 BREECH PRESENTATION 3 0.0024
135 GROWTH RETARDATION 7 0.0024
136 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 3 0.0023
137 HEPATIC CANCER METASTATIC 2 0.0023
138 OBLITERATIVE BRONCHIOLITIS 3 0.0023
139 PNEUMOMEDIASTINUM 4 0.0022
140 AMYLASE INCREASED 8 0.0022
141 ENDOTRACHEAL INTUBATION 6 0.0021
142 HEPATIC CANCER 50 0.0021
143 ANAEMIA NEONATAL 1 0.0021
144 HEPATIC MASS 4 0.0021
145 PNEUMONIA PNEUMOCOCCAL 3 0.0020
146 GENE MUTATION 4 0.0020
147 INTESTINAL ISCHAEMIA 11 0.0020
148 EMERGENCY CARE 6 0.0020
149 FULMINANT TYPE 1 DIABETES MELLITUS 2 0.0019
150 SLEEP TERROR 8 0.0019
151 ALANINE AMINOTRANSFERASE ABNORMAL 4 0.0019
152 BONE DEMINERALISATION 2 0.0019
153 ENTEROCOCCAL BACTERAEMIA 2 0.0019
154 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
155 HEPATIC NEOPLASM 6 0.0018
156 DRUG RESISTANCE 46 0.0018
157 RENAL TUBULAR DISORDER 5 0.0018
158 CREATININE RENAL CLEARANCE DECREASED 7 0.0017
159 MASTECTOMY 3 0.0017
160 MENINGITIS CRYPTOCOCCAL 3 0.0017
161 BILIRUBIN CONJUGATED INCREASED 4 0.0017
162 ALVEOLAR PROTEINOSIS 1 0.0017
163 LIVER TRANSPLANT REJECTION 3 0.0017
164 BILE DUCT STENOSIS 2 0.0017
165 VARICES OESOPHAGEAL 5 0.0017
166 IMMUNE-MEDIATED ENTEROCOLITIS 6 0.0016
167 AMPUTATION 2 0.0016
168 GLUCOSE URINE PRESENT 2 0.0016
169 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
170 OBSTRUCTION GASTRIC 2 0.0016
171 PHYSICAL DECONDITIONING 4 0.0016
172 HEPATIC CIRRHOSIS 29 0.0015
173 POSTMENOPAUSAL HAEMORRHAGE 4 0.0015
174 LIPIDS INCREASED 3 0.0015
175 FUNGAL SKIN INFECTION 6 0.0015
176 AORTITIS 1 0.0015
177 ANGULAR CHEILITIS 1 0.0014
178 GLOMERULAR FILTRATION RATE ABNORMAL 2 0.0014
179 HEPATIC PAIN 6 0.0014
180 PELVIC VENOUS THROMBOSIS 2 0.0014
181 RENAL TUBULAR ACIDOSIS 3 0.0014
182 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
183 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 3 0.0014
184 COCCYDYNIA 2 0.0014
185 THORACIC VERTEBRAL FRACTURE 4 0.0014
186 INFERTILITY 2 0.0013
187 MARASMUS 2 0.0013
188 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
189 VOLVULUS 3 0.0013
190 OSTEOPOROSIS 52 0.0013
191 DIABETES INSIPIDUS 3 0.0012
192 COLON CANCER METASTATIC 2 0.0012
193 IGA NEPHROPATHY 2 0.0012
194 QUADRIPARESIS 2 0.0012
195 DIALYSIS 17 0.0012
196 HYPERPARATHYROIDISM SECONDARY 3 0.0012
197 CACHEXIA 6 0.0012
198 ABSCESS DRAINAGE 1 0.0012
199 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
200 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
201 BLOOD LACTIC ACID INCREASED 6 0.0011
202 GASTROINTESTINAL OEDEMA 2 0.0011
203 LUNG TRANSPLANT 4 0.0011
204 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
205 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
206 GASTROINTESTINAL INJURY 3 0.0011
207 OPHTHALMIC HERPES ZOSTER 2 0.0011
208 BLOOD HIV RNA INCREASED 2 0.0011
209 PRODUCT DISPENSING ERROR 24 0.0011
210 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
211 DISEASE COMPLICATION 5 0.0011
212 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
213 PRODUCT DOSE OMISSION 71 0.0011
214 PARADOXICAL DRUG REACTION 4 0.0011
215 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
216 NEOPLASM MALIGNANT 72 0.0011
217 HEPATIC ENCEPHALOPATHY 10 0.0011
218 MYELOPATHY 2 0.0011
219 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
220 BICYTOPENIA 2 0.0010
221 HEPATITIS FULMINANT 3 0.0010
222 TRANSAMINASES INCREASED 22 0.0010
223 OSTEOPENIA 15 0.0010
224 IMMUNE-MEDIATED HEPATITIS 2 0.0010
225 RENAL MASS 2 0.0010
226 FOETAL DEATH 5 0.0010
227 LATENT TUBERCULOSIS 2 0.0010
228 LEUKAEMIA 9 0.0010
229 LUNG ABSCESS 2 0.0010
230 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
231 LIVER FUNCTION TEST INCREASED 20 0.0009
232 ECONOMIC PROBLEM 14 0.0009
233 ACINETOBACTER INFECTION 1 0.0009
234 RETROPERITONEAL HAEMATOMA 2 0.0009
235 HYPOALBUMINAEMIA 7 0.0009
236 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
237 CYTOPENIA 11 0.0009
238 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
239 CALCINOSIS 2 0.0009
240 NEPHROPATHY TOXIC 10 0.0009
241 ANHEDONIA 23 0.0009
242 HEPATIC FIBROSIS 3 0.0009
243 TRANSPLANT REJECTION 7 0.0009
244 VENTRICULAR EXTRASYSTOLES 9 0.0009
245 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
246 HEPATIC FAILURE 26 0.0009
247 LIVER DISORDER 38 0.0009
248 YELLOW SKIN 4 0.0009
249 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 7 0.0008
250 ALANINE AMINOTRANSFERASE INCREASED 52 0.0008
251 GASTROINTESTINAL OBSTRUCTION 2 0.0008
252 ADRENAL INSUFFICIENCY 10 0.0008
253 PRODUCT DOSE OMISSION IN ERROR 23 0.0008
254 RENAL IMPAIRMENT 68 0.0008
255 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
256 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
257 ABORTION MISSED 1 0.0008
258 HAEMORRHAGE URINARY TRACT 2 0.0008
259 TREATMENT NONCOMPLIANCE 43 0.0008
260 ABDOMINAL INFECTION 2 0.0008
261 RENAL DISORDER 36 0.0008
262 END STAGE RENAL DISEASE 14 0.0008
263 ACQUIRED GENE MUTATION 1 0.0008
264 LUNG OPACITY 2 0.0008
265 HEPATIC FUNCTION ABNORMAL 28 0.0007
266 HYPERLACTACIDAEMIA 2 0.0007
267 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
268 ABNORMAL FAECES 6 0.0007
269 NEPHROTIC SYNDROME 5 0.0007
270 LEG AMPUTATION 3 0.0007
271 SPINAL COMPRESSION FRACTURE 6 0.0007
272 LUNG CONSOLIDATION 2 0.0007
273 HAEMODIALYSIS 6 0.0007
274 ANAL HAEMORRHAGE 2 0.0007
275 TONGUE DISCOMFORT 3 0.0007
276 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
277 OESOPHAGEAL STENOSIS 2 0.0007
278 TUMOUR HAEMORRHAGE 2 0.0007
279 DUODENAL ULCER HAEMORRHAGE 2 0.0007
280 CARDIAC OPERATION 6 0.0007
281 CORONARY ARTERY BYPASS 4 0.0007
282 LUNG CANCER METASTATIC 2 0.0007
283 HEPATIC LESION 3 0.0007
284 OCULAR ICTERUS 3 0.0007
285 VOMITING PROJECTILE 2 0.0007
286 HAEMOTHORAX 2 0.0007
287 FRACTURE 13 0.0007
288 PROTEINURIA 13 0.0007
289 PARONYCHIA 3 0.0007
290 URINE ODOUR ABNORMAL 4 0.0007
291 DRUG ERUPTION 12 0.0007
292 CHRONIC KIDNEY DISEASE 51 0.0007
293 QUALITY OF LIFE DECREASED 9 0.0007
294 MIXED LIVER INJURY 2 0.0007
295 FOETAL EXPOSURE DURING PREGNANCY 54 0.0007
296 HYPERCAPNIA 2 0.0007
297 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0007
298 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
299 IMMUNE THROMBOCYTOPENIA 3 0.0007
300 CEREBRAL INFARCTION 16 0.0007
301 LUMBAR VERTEBRAL FRACTURE 3 0.0007
302 LIVER INJURY 16 0.0007
303 PORTAL HYPERTENSION 2 0.0006
304 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
305 LYMPHOMA 10 0.0006
306 RENAL FUNCTION TEST ABNORMAL 3 0.0006
307 PERFORMANCE STATUS DECREASED 3 0.0006
308 IRIDOCYCLITIS 2 0.0006
309 JAUNDICE 17 0.0006
310 LOW BIRTH WEIGHT BABY 5 0.0006
311 PRODUCT DOSE OMISSION ISSUE 184 0.0006
312 KIDNEY TRANSPLANT REJECTION 3 0.0006
313 CUSHINGOID 2 0.0006
314 HUMERUS FRACTURE 3 0.0006
315 HEPATITIS ACUTE 4 0.0006
316 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
317 BACTERIAL SEPSIS 2 0.0006
318 INFUSION SITE HAEMORRHAGE 2 0.0006
319 ANEURYSM 3 0.0006
320 SPLENOMEGALY 7 0.0006
321 SUBARACHNOID HAEMORRHAGE 6 0.0006
322 FEMORAL NECK FRACTURE 3 0.0006
323 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
324 AMYLOIDOSIS 1 0.0006
325 HYPERBILIRUBINAEMIA 6 0.0006
326 BLOOD CREATININE ABNORMAL 2 0.0006
327 GRANULOMA 2 0.0006
328 AUTOIMMUNE HEPATITIS 4 0.0006
329 DEMENTIA 16 0.0006
330 PRODUCT STORAGE ERROR 50 0.0006
331 ALOPECIA AREATA 1 0.0006
332 TUMOUR LYSIS SYNDROME 5 0.0006
333 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
334 DRUG INTERACTION 89 0.0006
335 COMPRESSION FRACTURE 3 0.0006
336 DECREASED ACTIVITY 6 0.0006
337 CARDIOVASCULAR DISORDER 14 0.0006
338 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
339 AGRANULOCYTOSIS 10 0.0005
340 TENDON INJURY 2 0.0005
341 PANCYTOPENIA 30 0.0005
342 NEPHROPATHY 5 0.0005
343 APPENDICITIS 5 0.0005
344 BONE DENSITY ABNORMAL 2 0.0005
345 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
346 HYDRONEPHROSIS 4 0.0005
347 ORAL CANDIDIASIS 7 0.0005
348 LOSS OF CONTROL OF LEGS 2 0.0005
349 FACE INJURY 2 0.0005
350 DYSPHAGIA 50 0.0005
351 HAEMODYNAMIC INSTABILITY 4 0.0005
352 BLOOD BILIRUBIN INCREASED 14 0.0005
353 MUSCLE RUPTURE 2 0.0005
354 AUTOIMMUNE DISORDER 5 0.0005
355 ASCITES 15 0.0005
356 TYPE 2 DIABETES MELLITUS 17 0.0005
357 PATENT DUCTUS ARTERIOSUS 2 0.0005
358 EXPOSURE VIA BREAST MILK 2 0.0005
359 FEBRILE NEUTROPENIA 33 0.0005
360 HEPATITIS C 6 0.0005
361 DRUG LEVEL DECREASED 5 0.0005
362 RECURRENT CANCER 2 0.0005
363 HICCUPS 4 0.0005
364 CHROMATURIA 11 0.0005
365 MULTIPLE FRACTURES 8 0.0005
366 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
367 CHOLANGITIS 3 0.0005
368 SOCIAL PROBLEM 2 0.0005
369 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
370 GASTROINTESTINAL PERFORATION 2 0.0005
371 LIVE BIRTH 4 0.0005
372 DRUG-INDUCED LIVER INJURY 15 0.0005
373 INFUSION SITE SWELLING 3 0.0005
374 ACUTE MYOCARDIAL INFARCTION 14 0.0005
375 MOUTH ULCERATION 10 0.0005
376 RENAL INJURY 14 0.0005
377 ABSCESS LIMB 2 0.0005
378 PRODUCT USE ISSUE 88 0.0005
379 PULMONARY TUBERCULOSIS 2 0.0005
380 SHOULDER OPERATION 2 0.0005
381 PRODUCT DISPENSING ISSUE 2 0.0005
382 THERAPY CESSATION 24 0.0005
383 ALCOHOLISM 2 0.0005
384 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
385 IMMOBILE 2 0.0005
386 URINE OUTPUT DECREASED 4 0.0005
387 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
388 ACCIDENT AT WORK 1 0.0005
389 SPINAL FRACTURE 9 0.0004
390 TERMINAL STATE 3 0.0004
391 BRAIN NEOPLASM MALIGNANT 2 0.0004
392 SURGERY 26 0.0004
393 PNEUMONIA ASPIRATION 11 0.0004
394 URINE ABNORMALITY 2 0.0004
395 ABDOMINAL HERNIA 2 0.0004
396 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
397 METASTASES TO LUNG 5 0.0004
398 LACTIC ACIDOSIS 14 0.0004
399 PAPULE 3 0.0004
400 ABORTION INDUCED 4 0.0004
401 COVID-19 PNEUMONIA 5 0.0004
402 INTENTIONAL PRODUCT USE ISSUE 37 0.0004
403 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
404 BACTERAEMIA 5 0.0004
405 SARCOIDOSIS 2 0.0004
406 METASTASIS 3 0.0004
407 NEURALGIA 10 0.0004
408 THERAPY CHANGE 4 0.0004
409 PSYCHIATRIC SYMPTOM 3 0.0004
410 PANCREATIC DISORDER 2 0.0004
411 HYPERVOLAEMIA 2 0.0004
412 COLON CANCER 6 0.0004
413 PROTEIN URINE PRESENT 2 0.0004
414 BRAIN INJURY 4 0.0004
415 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
416 ACUTE KIDNEY INJURY 60 0.0004
417 AMMONIA INCREASED 2 0.0004
418 HEPATITIS 10 0.0004
419 ENDOCARDITIS 2 0.0004
420 ABNORMAL UTERINE BLEEDING 1 0.0004
421 PRODUCT COLOUR ISSUE 2 0.0004
422 ANKLE FRACTURE 6 0.0004
423 RHABDOMYOLYSIS 16 0.0004
424 MALABSORPTION 2 0.0004
425 DELIRIUM 13 0.0004
426 STENT PLACEMENT 3 0.0004
427 PRODUCT RESIDUE PRESENT 2 0.0004
428 HIP SURGERY 2 0.0004
429 COVID-19 64 0.0004
430 PROSTATIC DISORDER 2 0.0004
431 GASTRIC ULCER HAEMORRHAGE 2 0.0004
432 LEUKOPENIA 18 0.0004
433 ATRIAL SEPTAL DEFECT 3 0.0004
434 PREMATURE LABOUR 2 0.0004
435 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
436 PERONEAL NERVE PALSY 2 0.0004
437 BONE DENSITY DECREASED 11 0.0004
438 PSEUDOMONAS INFECTION 3 0.0003
439 THERAPY INTERRUPTED 25 0.0003
440 VENTRICULAR SEPTAL DEFECT 2 0.0003
441 CYTOKINE RELEASE SYNDROME 7 0.0003
442 PSYCHOLOGICAL TRAUMA 3 0.0003
443 MYOPATHY 3 0.0003
444 ENTEROCOLITIS 2 0.0003
445 CAESAREAN SECTION 4 0.0003
446 NEUTROPHIL COUNT DECREASED 14 0.0003
447 ABORTION 1 0.0003
448 NEUROTOXICITY 6 0.0003
449 HYPERTRIGLYCERIDAEMIA 2 0.0003
450 METASTASES TO LIVER 6 0.0003
451 IMMUNOSUPPRESSION 3 0.0003
452 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
453 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
454 PULMONARY MASS 5 0.0003
455 HAEMOLYTIC ANAEMIA 3 0.0003
456 HAEMORRHAGE INTRACRANIAL 5 0.0003
457 PROTHROMBIN TIME PROLONGED 2 0.0003
458 MYOSITIS 3 0.0003
459 POLYNEUROPATHY 4 0.0003
460 HEPATITIS CHOLESTATIC 2 0.0003
461 PLATELET COUNT ABNORMAL 2 0.0003
462 FOETAL GROWTH RESTRICTION 2 0.0003
463 DERMATITIS ACNEIFORM 2 0.0003
464 PNEUMONIA BACTERIAL 3 0.0003
465 BRAIN NEOPLASM 3 0.0003
466 BONE PAIN 19 0.0003
467 HYPERCALCAEMIA 4 0.0003
468 RENAL FAILURE 43 0.0003
469 PRODUCT DISTRIBUTION ISSUE 3 0.0003
470 HEPATIC ENZYME INCREASED 22 0.0003
471 HEPATIC STEATOSIS 6 0.0003
472 BLOOD CREATININE INCREASED 21 0.0003
473 FLANK PAIN 3 0.0003
474 PLATELET COUNT DECREASED 34 0.0003
475 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
476 FOOT FRACTURE 6 0.0003
477 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
478 DIABETES MELLITUS 24 0.0003
479 ABSCESS 5 0.0003
480 POLLAKIURIA 13 0.0003
481 VITAMIN D DEFICIENCY 3 0.0003
482 RENAL TUBULAR NECROSIS 3 0.0003
483 DISABILITY 6 0.0003
484 INABILITY TO AFFORD MEDICATION 3 0.0003
485 DRUG LEVEL INCREASED 5 0.0003
486 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
487 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
488 CYTOMEGALOVIRUS INFECTION 5 0.0003
489 ANXIETY DISORDER 1 0.0003
490 PREMATURE BABY 9 0.0003
491 FULL BLOOD COUNT DECREASED 6 0.0003
492 METASTASES TO LYMPH NODES 2 0.0003
493 DEATH 254 0.0003
494 HELICOBACTER INFECTION 3 0.0003
495 LARGE INTESTINE POLYP 2 0.0003
496 PETECHIAE 3 0.0003
497 EXTRASYSTOLES 2 0.0003
498 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
499 FULL BLOOD COUNT ABNORMAL 3 0.0003
500 NEPHROLITHIASIS 13 0.0003
501 RENAL PAIN 3 0.0003
502 HAND FRACTURE 2 0.0003
503 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
504 APPENDICECTOMY 1 0.0003
505 SUBDURAL HAEMATOMA 4 0.0003
506 GRAFT VERSUS HOST DISEASE 2 0.0003
507 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
508 THROMBOCYTOPENIA 31 0.0003
509 PANIC REACTION 2 0.0003
510 HOSPITALISATION 42 0.0003
511 ORAL DISORDER 2 0.0003
512 STEVENS-JOHNSON SYNDROME 6 0.0003
513 IMMUNODEFICIENCY 4 0.0003
514 DEAFNESS 7 0.0003
515 KETOACIDOSIS 2 0.0003
516 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
517 EYE INFECTION 3 0.0003
518 GASTRIC ULCER 5 0.0003
519 AORTIC ANEURYSM 2 0.0003
520 MICTURITION URGENCY 3 0.0003
521 CHOLECYSTECTOMY 3 0.0003
522 INTERNAL HAEMORRHAGE 3 0.0003
523 HIP ARTHROPLASTY 4 0.0003
524 GASTRIC HAEMORRHAGE 3 0.0003
525 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
526 ACUTE MYELOID LEUKAEMIA 4 0.0003
527 HYPOXIA 9 0.0003
528 MULTIPLE ALLERGIES 2 0.0003
529 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
530 PRODUCT USE COMPLAINT 4 0.0003
531 HAEMATOCRIT DECREASED 5 0.0003
532 BLOOD ALBUMIN DECREASED 2 0.0003
533 CEREBRAL HAEMORRHAGE 9 0.0003
534 PRESCRIBED UNDERDOSE 5 0.0003
535 MYELOSUPPRESSION 9 0.0002
536 PRODUCT PHYSICAL ISSUE 5 0.0002
537 INTERSTITIAL LUNG DISEASE 12 0.0002
538 MYASTHENIA GRAVIS 2 0.0002
539 FRUSTRATION TOLERANCE DECREASED 2 0.0002
540 ANAEMIA 47 0.0002
541 ACCIDENTAL OVERDOSE 9 0.0002
542 DECUBITUS ULCER 2 0.0002
543 DECREASED APPETITE 57 0.0002
544 DYSURIA 9 0.0002
545 SMALL INTESTINAL OBSTRUCTION 3 0.0002
546 METASTASES TO BONE 4 0.0002
547 RIB FRACTURE 5 0.0002
548 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
549 GENERALISED OEDEMA 3 0.0002
550 PERITONITIS 5 0.0002
551 ILEUS 3 0.0002
552 TOOTH LOSS 5 0.0002
553 EOSINOPHIL COUNT INCREASED 2 0.0002
554 EMOTIONAL DISTRESS 29 0.0002
555 ABDOMINAL DISTENSION 25 0.0002
556 HYPOKALAEMIA 11 0.0002
557 SENSATION OF FOREIGN BODY 2 0.0002
558 GASTRIC CANCER 6 0.0002
559 OESOPHAGEAL CARCINOMA 7 0.0002
560 CIRCULATORY COLLAPSE 4 0.0002
561 HYPOPHAGIA 6 0.0002
562 FACIAL PARALYSIS 2 0.0002
563 VITAMIN D DECREASED 2 0.0002
564 IMPAIRED WORK ABILITY 5 0.0002
565 ROTATOR CUFF SYNDROME 3 0.0002
566 PRODUCT CONTAINER ISSUE 2 0.0002
567 INFUSION SITE PAIN 3 0.0002
568 BLOOD POTASSIUM DECREASED 7 0.0002
569 BLOOD MAGNESIUM DECREASED 2 0.0002
570 PYELONEPHRITIS 2 0.0002
571 FAECES DISCOLOURED 5 0.0002
572 BEDRIDDEN 3 0.0002
573 GROIN PAIN 2 0.0002
574 ABDOMINAL ABSCESS 1 0.0002
575 THIRST 4 0.0002
576 ORAL PAIN 5 0.0002
577 ANAL INCONTINENCE 2 0.0002
578 OROPHARYNGEAL DISCOMFORT 2 0.0002
579 LEUKOCYTOSIS 4 0.0002
580 ACUTE HEPATIC FAILURE 3 0.0002
581 HIDRADENITIS 2 0.0002
582 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
583 IRON DEFICIENCY ANAEMIA 2 0.0002
584 DIARRHOEA HAEMORRHAGIC 2 0.0002
585 PRODUCT USE IN UNAPPROVED INDICATION 52 0.0002
586 GAIT INABILITY 7 0.0002
587 PANCREATIC CARCINOMA 6 0.0002
588 GLAUCOMA 4 0.0002
589 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
590 MYELODYSPLASTIC SYNDROME 3 0.0002
591 SEPTIC SHOCK 9 0.0002
592 MENTAL DISORDER 9 0.0002
593 BACK PAIN 48 0.0002
594 DIZZINESS POSTURAL 2 0.0002
595 THROMBOTIC MICROANGIOPATHY 2 0.0002
596 PARKINSONISM 2 0.0002
597 HAEMORRHOIDS 4 0.0002
598 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
599 HEPATOMEGALY 2 0.0002
600 DYSPEPSIA 20 0.0002
601 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
602 BONE LOSS 3 0.0002
603 HYPERTENSION 42 0.0002
604 UNEVALUABLE EVENT 15 0.0002
605 PERITONITIS BACTERIAL 2 0.0002
606 LYMPHADENOPATHY 7 0.0002
607 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
608 HYPOTHERMIA 2 0.0002
609 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
610 TASTE DISORDER 4 0.0002
611 OFF LABEL USE 172 0.0002
612 INSURANCE ISSUE 3 0.0002
613 SLUGGISHNESS 2 0.0002
614 CEREBROVASCULAR ACCIDENT 33 0.0002
615 LUNG NEOPLASM MALIGNANT 8 0.0002
616 THERAPY PARTIAL RESPONDER 3 0.0002
617 APLASTIC ANAEMIA 1 0.0002
618 KNEE ARTHROPLASTY 4 0.0002
619 NEUROPATHY PERIPHERAL 18 0.0002
620 PANCREATITIS 10 0.0002
621 SUDDEN DEATH 2 0.0002
622 PREMATURE DELIVERY 3 0.0002
623 SEPSIS 21 0.0002
624 MYALGIA 32 0.0002
625 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
626 FATIGUE 144 0.0002
627 OSTEONECROSIS 6 0.0002
628 ASPIRATION 2 0.0002
629 PYREXIA 63 0.0002
630 TREATMENT FAILURE 15 0.0002
631 COAGULOPATHY 3 0.0002
632 URINARY RETENTION 6 0.0002
633 PLASMA CELL MYELOMA 7 0.0002
634 PULMONARY EMBOLISM 17 0.0002
635 CELLULITIS 9 0.0002
636 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
637 ACUTE PULMONARY OEDEMA 1 0.0002
638 OCULAR DISCOMFORT 2 0.0002
639 CHEST DISCOMFORT 18 0.0002
640 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
641 RED BLOOD CELL COUNT DECREASED 5 0.0002
642 GASTRIC DISORDER 6 0.0002
643 CONDITION AGGRAVATED 53 0.0002
644 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
645 MUSCLE TWITCHING 4 0.0002
646 EXTRA DOSE ADMINISTERED 7 0.0002
647 ELECTROLYTE IMBALANCE 2 0.0002
648 LIVER FUNCTION TEST ABNORMAL 5 0.0002
649 VASCULITIS 2 0.0002
650 RASH MACULAR 6 0.0002
651 BLOOD CHOLESTEROL INCREASED 8 0.0002
652 DEPRESSION 39 0.0002
653 DYSSTASIA 5 0.0002
654 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
655 BLOOD IRON DECREASED 2 0.0002
656 MYOCLONUS 2 0.0002
657 HYPERLIPIDAEMIA 2 0.0002
658 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
659 WHITE BLOOD CELL COUNT DECREASED 18 0.0002
660 OEDEMA 9 0.0002
661 RASH 72 0.0002
662 HYPOGLYCAEMIA 8 0.0002
663 BONE DISORDER 3 0.0002
664 SCHIZOPHRENIA 2 0.0002
665 ENCEPHALOPATHY 4 0.0002
666 SPINAL OPERATION 2 0.0002
667 OSTEONECROSIS OF JAW 4 0.0002
668 FEMUR FRACTURE 5 0.0002
669 PRURITUS 62 0.0002
670 PNEUMONIA 52 0.0002
671 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
672 POISONING 2 0.0002
673 INTESTINAL OBSTRUCTION 6 0.0002
674 BLOOD SODIUM DECREASED 3 0.0002
675 DERMATITIS ALLERGIC 2 0.0002
676 MUSCULAR WEAKNESS 18 0.0002
677 PULMONARY FIBROSIS 3 0.0002
678 CHOLESTASIS 3 0.0002
679 SEROTONIN SYNDROME 3 0.0002
680 MOVEMENT DISORDER 5 0.0002
681 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
682 ORAL HERPES 3 0.0002
683 STAPHYLOCOCCAL INFECTION 5 0.0002
684 DEPRESSED MOOD 8 0.0002
685 ABDOMINAL PAIN UPPER 31 0.0002
686 BREAST CANCER 14 0.0002
687 EYE HAEMORRHAGE 2 0.0001
688 ABORTION SPONTANEOUS 6 0.0001
689 DIARRHOEA 96 0.0001
690 FEEDING DISORDER 3 0.0001
691 BONE MARROW FAILURE 3 0.0001
692 RASH PRURITIC 8 0.0001
693 TACHYPNOEA 2 0.0001
694 NEUTROPENIA 20 0.0001
695 HEADACHE 92 0.0001
696 IMPAIRED GASTRIC EMPTYING 2 0.0001
697 ABNORMAL LOSS OF WEIGHT 1 0.0001
698 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
699 PALPITATIONS 17 0.0001
700 HAEMATOCHEZIA 8 0.0001
701 EXPOSURE DURING PREGNANCY 9 0.0001
702 MENTAL STATUS CHANGES 4 0.0001
703 HUNGER 2 0.0001
704 DERMATITIS 3 0.0001
705 BLOOD TEST ABNORMAL 2 0.0001
706 FLATULENCE 8 0.0001
707 PARALYSIS 2 0.0001
708 CARDIOGENIC SHOCK 2 0.0001
709 IMPAIRED QUALITY OF LIFE 2 0.0001
710 DEEP VEIN THROMBOSIS 9 0.0001
711 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
712 ALOPECIA 27 0.0001
713 C-REACTIVE PROTEIN INCREASED 5 0.0001
714 HYPERGLYCAEMIA 5 0.0001
715 DRY MOUTH 11 0.0001
716 LABORATORY TEST ABNORMAL 4 0.0001
717 INSOMNIA 36 0.0001
718 HEPATOTOXICITY 3 0.0001
719 MUSCULOSKELETAL PAIN 7 0.0001
720 THERAPY NON-RESPONDER 6 0.0001
721 HEART RATE IRREGULAR 3 0.0001
722 NO ADVERSE EVENT 24 0.0001
723 CORONARY ARTERY DISEASE 4 0.0001
724 PLEURAL EFFUSION 8 0.0001
725 DRUG DISPENSING ERROR 2 0.0001
726 ACIDOSIS 1 0.0001
727 ANXIETY 37 0.0001
728 THYROID DISORDER 2 0.0001
729 HYPOTENSION 26 0.0001
730 APNOEA 1 0.0001
731 NERVOUS SYSTEM DISORDER 4 0.0001
732 DISEASE PROGRESSION 15 0.0001
733 ILLNESS 13 0.0001
734 COMA 6 0.0001
735 HYPOTHYROIDISM 4 0.0001
736 ASTHENIA 47 0.0001
737 DIABETIC KETOACIDOSIS 3 0.0001
738 ABDOMINAL PAIN 29 0.0001
739 SENSORY DISTURBANCE 2 0.0001
740 CARDIAC FAILURE 10 0.0001
741 NIGHT SWEATS 4 0.0001
742 LOCALISED INFECTION 3 0.0001
743 MUSCLE TIGHTNESS 2 0.0001
744 BLOOD POTASSIUM INCREASED 2 0.0001
745 AMNESIA 8 0.0001
746 BLINDNESS 5 0.0001
747 ARTHRALGIA 51 0.0001
748 DIZZINESS 61 0.0001
749 HERPES ZOSTER 7 0.0001
750 VENTRICULAR TACHYCARDIA 2 0.0001
751 FUNGAL INFECTION 4 0.0001
752 BLOOD UREA INCREASED 2 0.0001
753 CHILLS 14 0.0001
754 ABDOMINAL DISCOMFORT 20 0.0001
755 PRODUCT COMPLAINT 3 0.0001
756 HAEMATEMESIS 3 0.0001
757 OSTEOARTHRITIS 5 0.0001
758 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
759 MEMORY IMPAIRMENT 16 0.0001
760 INFLAMMATION 6 0.0001
761 NAUSEA 92 0.0001
762 SKIN ULCER 3 0.0001
763 STOMATITIS 7 0.0001
764 ILL-DEFINED DISORDER 7 0.0001
765 ORTHOSTATIC HYPOTENSION 2 0.0001
766 HAEMORRHAGE 12 0.0001
767 DISCOMFORT 7 0.0001
768 EOSINOPHILIA 2 0.0001
769 AMENORRHOEA 2 0.0001
770 GASTRITIS 3 0.0001
771 DRUG INTOLERANCE 11 0.0001
772 HYPOAESTHESIA 17 0.0001
773 LYMPHOCYTE COUNT DECREASED 2 0.0001
774 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
775 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
776 DEHYDRATION 15 0.0001
777 ISCHAEMIC STROKE 2 0.0001
778 GALLBLADDER DISORDER 2 0.0001
779 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
780 URINARY TRACT INFECTION 19 0.0001
781 PNEUMONITIS 3 0.0001
782 PELVIC PAIN 2 0.0001
783 SYNCOPE 11 0.0001
784 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
785 ADVERSE EVENT 10 0.0001
786 PAIN 66 0.0001
787 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
788 BACTERIAL INFECTION 2 0.0001
789 OEDEMA PERIPHERAL 13 0.0001
790 ANGINA PECTORIS 3 0.0001
791 INCREASED APPETITE 2 0.0001
792 ACUTE RESPIRATORY FAILURE 2 0.0001
793 WEIGHT DECREASED 29 0.0001
794 INFECTION 15 0.0001
795 INTENTIONAL PRODUCT MISUSE 9 0.0001
796 DYSPHONIA 6 0.0001
797 CHOKING 2 0.0001
798 VOMITING 48 0.0001
799 KIDNEY INFECTION 2 0.0001
800 BLOOD PRESSURE ABNORMAL 2 0.0001
801 UPPER LIMB FRACTURE 2 0.0001
802 ADVERSE DRUG REACTION 9 0.0001
803 INJURY 7 0.0001
804 THROMBOSIS 8 0.0001
805 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
806 GAIT DISTURBANCE 19 0.0001
807 PSORIATIC ARTHROPATHY 4 0.0001
808 SUICIDAL IDEATION 9 0.0001
809 MYOCARDIAL INFARCTION 17 0.0001
810 MOBILITY DECREASED 7 0.0001
811 TREMOR 16 0.0001
812 CARDIAC DISORDER 9 0.0001
813 RESPIRATORY FAILURE 7 0.0001
814 ROAD TRAFFIC ACCIDENT 4 0.0001
815 AGITATION 7 0.0001
816 SEIZURE 11 0.0001
817 DRUG INEFFECTIVE 125 0.0001
818 DYSGEUSIA 7 0.0001
819 EATING DISORDER 2 0.0001
820 METABOLIC ACIDOSIS 3 0.0001
821 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
822 FALL 31 0.0001
823 POOR QUALITY SLEEP 2 0.0001
824 COUGH 26 0.0001
825 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
826 SWELLING FACE 6 0.0001
827 PRODUCT PRESCRIBING ISSUE 2 0.0001
828 CONSTIPATION 20 0.0001
829 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
830 CHOLELITHIASIS 3 0.0001
831 IMPAIRED HEALING 3 0.0001
832 MELAENA 2 0.0001
833 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
834 TACHYCARDIA 8 0.0001
835 ARTHROPATHY 5 0.0001
836 MEDICATION ERROR 5 0.0001
837 RASH MACULO-PAPULAR 2 0.0001
838 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
839 SNEEZING 2 0.0001
840 RHEUMATOID ARTHRITIS 10 0.0001
841 LETHARGY 5 0.0001
842 PERICARDIAL EFFUSION 2 0.0001
843 LOSS OF CONSCIOUSNESS 11 0.0001
844 COGNITIVE DISORDER 4 0.0001
845 HYPERKALAEMIA 3 0.0001
846 HEART RATE DECREASED 3 0.0001
847 SLEEP DISORDER 6 0.0001
848 WEIGHT INCREASED 19 0.0001
849 CARDIAC ARREST 7 0.0001
850 ARRHYTHMIA 4 0.0001
851 SOMNOLENCE 17 0.0001
852 ACCIDENT 1 0.0001
853 RASH ERYTHEMATOUS 4 0.0001
854 TOXICITY TO VARIOUS AGENTS 14 0.0001
855 SKIN EXFOLIATION 7 0.0001
856 PRESYNCOPE 2 0.0001
857 BALANCE DISORDER 7 0.0001
858 AGEUSIA 2 0.0001
859 DRY EYE 4 0.0001
860 DYSARTHRIA 3 0.0001
861 DYSPNOEA EXERTIONAL 3 0.0001
862 DYSPNOEA 45 0.0001
863 COLITIS 3 0.0001
864 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
865 GASTROINTESTINAL DISORDER 7 0.0001
866 MALAISE 34 0.0001
867 ECZEMA 4 0.0001
868 HYPERSENSITIVITY 14 0.0001
869 ADVERSE REACTION 1 0.0001
870 PAIN IN EXTREMITY 22 0.0001
871 PROSTATE CANCER 6 0.0001
872 FREQUENT BOWEL MOVEMENTS 2 0.0001
873 SKIN LESION 2 0.0001
874 RESPIRATORY DISTRESS 2 0.0001
875 ATRIAL FIBRILLATION 7 0.0001
876 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
877 CARDIO-RESPIRATORY ARREST 3 0.0001
878 APHONIA 1 0.0001
879 URTICARIA 12 0.0001
880 PERIPHERAL SWELLING 11 0.0001
881 OXYGEN SATURATION DECREASED 4 0.0001
882 EYE PAIN 4 0.0001
883 PAIN IN JAW 2 0.0001
884 SKIN BURNING SENSATION 5 0.0001
885 ACCIDENTAL UNDERDOSE 1 0.0001
886 APATHY 1 0.0001
887 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
888 HAEMOGLOBIN DECREASED 7 0.0001
889 ANGIOEDEMA 3 0.0001
890 URINARY INCONTINENCE 2 0.0001
891 RESPIRATORY DISORDER 2 0.0001
892 APHASIA 2 0.0001
893 LACRIMATION INCREASED 2 0.0001
894 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
895 THERAPEUTIC RESPONSE DECREASED 4 0.0001
896 SUICIDE ATTEMPT 4 0.0001
897 EPILEPSY 2 0.0001
898 FEELING HOT 4 0.0001
899 NASOPHARYNGITIS 12 0.0001
900 SWELLING 6 0.0001
901 HEAD INJURY 2 0.0001
902 PRODUCTIVE COUGH 3 0.0001
903 CYSTITIS 2 0.0001
904 CARDIAC FAILURE CONGESTIVE 5 0.0001
905 LUNG DISORDER 3 0.0001
906 EYE DISORDER 2 0.0001
907 INFUSION RELATED REACTION 4 0.0001
908 VIRAL INFECTION 2 0.0001
909 SKIN DISORDER 2 0.0001
910 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
911 HAEMATURIA 2 0.0001
912 VISION BLURRED 8 0.0001
913 NIGHTMARE 2 0.0001
914 SPEECH DISORDER 3 0.0001
915 PARAESTHESIA 9 0.0001
916 DRUG WITHDRAWAL SYNDROME 5 0.0001
917 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
918 DISTURBANCE IN ATTENTION 3 0.0001
919 CRYING 2 0.0001
920 RESTLESSNESS 2 0.0001
921 BRONCHITIS 4 0.0001
922 EYE SWELLING 2 0.0001
923 NECK PAIN 3 0.0001
924 PSORIASIS 7 0.0001
925 EPISTAXIS 4 0.0001
926 BLISTER 3 0.0001
927 HYPONATRAEMIA 3 0.0001
928 DRY SKIN 7 0.0001
929 BLOOD PRESSURE INCREASED 8 0.0001
930 OVERDOSE 11 0.0001
931 ARTHRITIS 4 0.0001
932 WHEEZING 3 0.0001
933 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
934 DISORIENTATION 2 0.0001
935 HEART RATE INCREASED 5 0.0001
936 VERTIGO 3 0.0000
937 INFLUENZA LIKE ILLNESS 4 0.0000
938 CHEST PAIN 9 0.0000
939 BLOOD GLUCOSE INCREASED 9 0.0000
940 HYPERHIDROSIS 6 0.0000
941 RECTAL HAEMORRHAGE 2 0.0000
942 HYPOACUSIS 2 0.0000
943 RHINORRHOEA 3 0.0000
944 MUSCULOSKELETAL STIFFNESS 4 0.0000
945 COLITIS ULCERATIVE 2 0.0000
946 THROAT IRRITATION 2 0.0000
947 ASTHMA 5 0.0000
948 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
949 SKIN IRRITATION 2 0.0000
950 MUSCLE SPASMS 8 0.0000
951 SKIN DISCOLOURATION 2 0.0000
952 OROPHARYNGEAL PAIN 4 0.0000
953 DRUG DOSE OMISSION 7 0.0000
954 DISEASE RECURRENCE 2 0.0000
955 MULTIPLE SCLEROSIS 2 0.0000
956 BLOOD GLUCOSE DECREASED 2 0.0000
957 JOINT SWELLING 5 0.0000
958 AGGRESSION 2 0.0000
959 HALLUCINATION 3 0.0000
960 HOT FLUSH 3 0.0000
961 ACNE 3 0.0000
962 ABDOMINAL PAIN LOWER 1 0.0000
963 FLUSHING 4 0.0000
964 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
965 ANAPHYLACTIC SHOCK 1 0.0000
966 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
967 DERMATITIS ATOPIC 2 0.0000
968 BRADYCARDIA 2 0.0000
969 CONFUSIONAL STATE 6 0.0000
970 INFLUENZA 4 0.0000
971 EYE IRRITATION 2 0.0000
972 PRODUCT SUBSTITUTION ISSUE 2 0.0000
973 NASAL CONGESTION 2 0.0000
974 CATARACT 2 0.0000
975 FEELING ABNORMAL 8 0.0000
976 IRRITABILITY 2 0.0000
977 BLOOD PRESSURE DECREASED 2 0.0000
978 INJECTION SITE PRURITUS 2 0.0000
979 PRODUCT QUALITY ISSUE 4 0.0000
980 UNDERDOSE 2 0.0000
981 ERYTHEMA 5 0.0000
982 VISUAL IMPAIRMENT 3 0.0000
983 DRUG ABUSE 2 0.0000
984 COMPLETED SUICIDE 2 0.0000
985 INCORRECT DOSE ADMINISTERED 5 0.0000
986 MIGRAINE 2 0.0000
987 CONTUSION 2 0.0000
988 SINUSITIS 2 0.0000
989 INJECTION SITE PAIN 3 0.0000
990 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000